APA (7th ed.) Citation

JH, J., YR, S., SR, Y., HB, L., HJ, L., HJ, C., . . . YH, L. (2026). Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells. Molecular therapy. Oncology, 34(1), 201158. https://doi.org/10.1016/j.omton.2026.201158

Chicago Style (17th ed.) Citation

JH, Jeong, Seo YR, Yu SR, Lee HB, Lee HJ, Cho HJ, Kim HC, and Lee YH. "Antigen-binding Affinity Is a Key Determinant of the Durable Antitumor Activity of CD5 CAR-T Cells." Molecular Therapy. Oncology 34, no. 1 (2026): 201158. https://doi.org/10.1016/j.omton.2026.201158.

MLA (9th ed.) Citation

JH, Jeong, et al. "Antigen-binding Affinity Is a Key Determinant of the Durable Antitumor Activity of CD5 CAR-T Cells." Molecular Therapy. Oncology, vol. 34, no. 1, 2026, p. 201158, https://doi.org/10.1016/j.omton.2026.201158.